Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C15H22ClN3O3 |
| Molecular Weight | 327.806 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCNCCNC(=O)C1=C(OC(C)C(C)=O)C=C(N)C(Cl)=C1
InChI
InChIKey=ZRUMCJHVXNLVLW-UHFFFAOYSA-N
InChI=1S/C15H22ClN3O3/c1-4-18-5-6-19-15(21)11-7-12(16)13(17)8-14(11)22-10(3)9(2)20/h7-8,10,18H,4-6,17H2,1-3H3,(H,19,21)
| Molecular Formula | C15H22ClN3O3 |
| Molecular Weight | 327.806 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:33:47 GMT 2023
by
admin
on
Sat Dec 16 11:33:47 GMT 2023
|
| Record UNII |
AK0HP8U7FO
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
101658374
Created by
admin on Sat Dec 16 11:33:48 GMT 2023 , Edited by admin on Sat Dec 16 11:33:48 GMT 2023
|
PRIMARY | |||
|
AK0HP8U7FO
Created by
admin on Sat Dec 16 11:33:48 GMT 2023 , Edited by admin on Sat Dec 16 11:33:48 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
longer elimination half-life of the three
metabolites versus the parent compound in subjects with
normal renal function, the disposition of the metabolites
of batanopride appears to be elimination-rate limited. All
three metabolites had increased AUC and half-life and reduced renal clearance as renal function worsened
MAJOR
PLASMA
|
